Skip to main content
Log in

Dronedarone + DOACs: risk of major bleeding

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Gandhi SK, et al. Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database). American Journal of Cardiology 159: 79-86, 15 Nov 2021. Available from: URL: http://doi.org/10.1016/j.amjcard.2021.08.015

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dronedarone + DOACs: risk of major bleeding. Reactions Weekly 1879, 8 (2021). https://doi.org/10.1007/s40278-021-04492-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-04492-6

Navigation